title: Octreotide treatment of chemotherapy-induced diarrhoea.
authors.forename: P
authors.initials: P
authors.lastname: Ginopoulos
authors.forename: T
authors.initials: T
authors.lastname: Papagiannis
authors.forename: C
authors.initials: C
authors.lastname: Safridi
authors.forename: F
authors.initials: F
authors.lastname: Karvelas
authors.forename: K
authors.initials: K
authors.lastname: Spyropoulos
authors.forename: T
authors.initials: T
authors.lastname: Papadas
authors.forename: C
authors.initials: C
authors.lastname: Gogos
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003967:Diarrhea / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D005765:Gastrointestinal Agents; D015282:Octreotide; D005472:Fluorouracil